The results of this study enhance the understanding that SPNS3 promotes resistance against apoptosis, which accounts for the poor survival in AML to some extent, and high SPNS3 expression is a marker of poor prognosis in AML that is mediated through its anti-apoptotic effect. The gene discussed is SPNS3; the disease is acute myeloid leukemia.